drugset / Trial / NCT07261306

Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis

NCT07261306

Phase 0 Recruiting 75 enrolled Lahore General Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Psoriasis is a chronic inflammatory dermatoses which include well demarcated scaly erythematous plaques on whole body including scalp role of methotrexate vs tofacitinib is compared in this study

Timeline

Start
2025-08-29
Primary completion
2025-12-10
Completion
2025-12-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methotrexate Small molecule
Comparator Tofacitinib Small molecule

Indications